Jason Dubner speaks with NPR about generic drug price fixing
Jason Dubner was interviewed in the NPR article, "Probe into generic drug price fixing set to widen." The article discusses claims from 45 states and the U.S. Department of Justice that generic drug prices are fixed, potentially costing businesses and consumers more than $1 billion.
Jason Dubner says the allegations are so massive that prices throughout the generic industry could have been affected. "You start to get an understanding just how widespread this alleged conspiracy was to cover so many different types of cures," he says.